Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: Results of a prospective randomized double-blinded placebo-controlled trial

European Journal of Surgical Oncology

Volumn 34, Issue 8, 2008, Pages 868-875

  Kollmar, O ^a   Moussavian, M R ^a   Richter, S ^a   de Roi, P ^a   Maurer, C A ^b   Schilling, M K ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Liestal Hospital   (Switzerland)

Author keywords

Delayed gastric emptying; Pancreaticoduodenectomy; Postoperative pancreatic fistula; Prophylactic octreotide

Indexed keywords

OCTREOTIDE; PLACEBO; TECHNETIUM TIN COLLOID TC 99M;

ABDOMINAL BLEEDING; ADULT; AGED; ARTICLE; BILIARY STENTING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED STOMACH EMPTYING; DOUBLE BLIND PROCEDURE; FEMALE; GASTRIC DYSMOTILITY; HUMAN; HYDROGEN BREATH TEST; INCIDENCE; INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; PANCREAS FISTULA; PANCREATICODUODENECTOMY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STENT; STOMACH EMPTYING; STOMACH SCINTISCANNING; UNIVARIATE ANALYSIS;

AGED; DOUBLE-BLIND METHOD; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; OCTREOTIDE; PANCREATIC FISTULA; PANCREATICODUODENECTOMY; RISK FACTORS; TREATMENT OUTCOME;

EID: 46949099060     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.01.014     Document Type: Article

References (46)

1. Winter J.M., Cameron J.L., Campbell K.A., et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10 (2006) 1199-1210
2. van Berge Henegouwen M.I., van Gulik T.M., Akkermans L.M., et al. The effect of octreotide on gastric emptying at a dosage used to prevent complications after pancreatic surgery: a randomised, placebo controlled study in volunteers. Gut 41 (1997) 758-762
3. Murakami H., Suzuki H., and Nakamura T. Pancreatic fibrosis correlates with delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy with pancreaticogastrostomy. Ann Surg 235 (2002) 240-245
4. Bassi C., Dervenis C., Butturini G., et al. International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138 (2005) 8-13
5. Warshaw A.L., and Torchiana D.L. Delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy. Surg Gynecol Obstet 160 (1985) 1-4
6. Yeo C.J., Cameron J.L., Sohn T.A., et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226 (1997) 248-257
7. Ohwada S., Satoh Y., Kawate S., et al. Low-dose erythromycin reduces delayed gastric emptying and improves gastric motility after Billroth I pylorus-preserving pancreaticoduodenectomy. Ann Surg 234 (2001) 668-674
8. Kimura F., Suwa T., Sugiura T., et al. Sepsis delays gastric emptying following pylorus-preserving pancreaticoduodenectomy. Hepatogastroenterology 49 (2002) 585-588
9. Nguyen N.Q., Chapman M.J., Fraser R.J., et al. Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness. Crit Care Med 35 (2007) 483-489
10. Lermite E., Pessaux P., Brehant O., et al. Risk factors of pancreatic fistula and delayed gastric emptying after pancreaticoduodenectomy with pancreaticogastrostomy. J Am Coll Surg 204 (2007) 588-596
11. Liberski S.M., Koch K.L., Atnip R.G., et al. Ischemic gastroparesis: resolution after revascularization. Gastroenterology 99 (1990) 252-257
12. Kim D.K., Hindenburg A.A., Sharma S.K., et al. Is pylorospasm a cause of delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy?. Ann Surg Oncol 12 (2005) 222-227
13. Malfertheiner P., Sarr M.G., Nelson D.K., et al. Role of the duodenum in postprandial release of pancreatic and gastrointestinal hormones. Pancreas 9 (1994) 13-19
14. van Berge Henegouwen M.I., van Gulik T.M., DeWit L.T., et al. Delayed gastric emptying after standard pancreaticoduodenectomy versus pylorus-preserving pancreaticoduodenectomy: an analysis of 200 consecutive patients. J Am Coll Surg 185 (1997) 373-379
15. Goei T.H., Henegouwen M.I., Slooff M.J., et al. Pylorus-preserving pancreatoduodenectomy: influence of a Billroth I versus a Billroth II type of reconstruction on gastric emptying. Dig Surg 18 (2001) 376-380
16. Bassi C., Falconi M., Molinari E., et al. Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study. Ann Surg 242 (2005) 767-771
17. Levein N.G., Thorn S.E., and Wattwil M. Dopamine delays gastric emptying and prolongs orocaecal transit time in volunteers. Eur J Anaesthesiol 16 (1999) 246-250
18. Martignoni M.E., Friess H., Sell F., et al. Enteral nutrition prolongs delayed gastric emptying in patients after Whipple resection. Am J Surg 180 (2000) 18-23
19. Buchler M., Friess H., Klempa I., et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 163 (1992) 125-130
20. Berberat P.O., Friess H., Uhl W., et al. The role of octreotide in the prevention of complications following pancreatic resection. Digestion 60 Suppl. 2 (1999) 15-22
21. Li-Ling J., and Irving M. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Br J Surg 88 (2001) 190-199
22. Suc B., Msika S., Piccinini M., et al. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial. Arch Surg 139 (2004) 288-294
23. Hesse U.J., DeDecker C., Houtmeyers P., et al. Prospectively randomized trial using perioperative low-dose octreotide to prevent organ-related and general complications after pancreatic surgery and pancreatico-jejunostomy. World J Surg 29 (2005) 1325-1328
24. Nelson-Piercy C., Hammond P.J., Gwilliam M.E., et al. Effect of a new oral somatostatin analog (SDZ CO 611) on gastric emptying, mouth to cecum transit time, and pancreatic and gut hormone release in normal male subjects. J Clin Endocrinol Metab 78 (1994) 329-336
25. Fuessl H.S., Carolan G., Williams G., et al. Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man. Digestion 36 (1987) 101-107
26. Li-Ling J., and Irving M. Therapeutic value of octreotide for patients with severe dumping syndrome - a review of randomised controlled trials. Postgrad Med J 77 (2001) 441-442
27. Seiler C.A., Wagner M., Sadowski C., et al. Randomized prospective trial of pylorus-preserving vs. Classic duodenopancreatectomy (Whipple procedure): initial clinical results. J Gastrointest Surg 4 (2000) 443-452
28. Kawarada Y., and Isaji S. Stage classifications of pancreatic cancer: comparison of the Japanese and UICC classifications and proposal for a new staging system. Union Internationale Contre le Cancer. Pancreas 16 (1998) 255-264
29. Pessaux P., Varma D., and Arnaud J.P. Pancreaticoduodenectomy: superior mesenteric artery first approach. J Gastrointest Surg 10 (2006) 607-611
30. Linke R., Meier M., Muenzing W., et al. Prokinetic therapy: what can be measured by gastric scintigraphy?. Nucl Med Commun 26 (2005) 527-533
31. Di Stefano M., Missanelli A., Miceli E., et al. Hydrogen breath test in the diagnosis of lactose malabsorption: accuracy of new versus conventional criteria. J Lab Clin Med 144 (2004) 313-318
32. Lowy A.M., Lee J.E., Pisters P.W., et al. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 226 (1997) 632-641
33. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 232 (2000) 419-429
34. Pederzoli P., Bassi C., Falconi M., et al. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg 81 (1994) 265-269
35. Montorsi M., Zago M., Mosca F., et al. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery 117 (1995) 26-31
36. Friess H., Beger H.G., Sulkowski U., et al. Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 82 (1995) 1270-1273
37. Harris A.G. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. Gut 35 (1994) S1-S4
38. Foxx-Orenstein A., Camilleri M., Stephens D., et al. Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut 52 (2003) 1555-1561
39. Haruma K., Wiste J.A., and Camilleri M. Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders. Gut 35 (1994) 1064-1069
40. O'Donnell L.J., Watson A.J., Cameron D., et al. Effect of octreotide on mouth-to-caecum transit time in healthy subjects and in the irritable bowel syndrome. Aliment Pharmacol Ther 4 (1990) 177-181
41. Geer R.J., Richards W.O., O'Dorisio T.M., et al. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann Surg 212 (1990) 678-687
42. Yeo C.J., Barry M.K., Sauter P.K., et al. Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg 218 (1993) 229-237
43. Park Y.C., Kim S.W., Jang J.Y., et al. Factors influencing delayed gastric emptying after pylorus-preserving pancreatoduodenectomy. J Am Coll Surg 196 (2003) 859-865
44. Lin P.W., and Lin Y.J. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 86 (1999) 603-607
45. Horstmann O., Markus P.M., Ghadimi M.B., et al. Pylorus preservation has no impact on delayed gastric emptying after pancreatic head resection. Pancreas 28 (2004) 69-74
46. Shan Y.S., Sy E.D., Tsai M.L., et al. Effects of somatostatin prophylaxis after pylorus-preserving pancreaticoduodenectomy: increased delayed gastric emptying and reduced plasma motilin. World J Surg 29 (2005) 1319-1324